Episode 559: SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes

POEM of the Week Podcast - En podkast av Mark Ebell and Michael Wilkes

Prøv Podimo gratis i hele 60! dager!

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

 Reklame

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes '

Visit the podcast's native language site